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Summary
Objectives: To examine the localization of bone morphogenetic protein (BMP)-2 mRNA and protein in human osteoarthritic (OA) articular
cartilage and osteophyte.
Design: Five normal, four growing and 14 OA human cartilage samples, graded histomorphologically by Mankin Score, were studied by
in situ hybridization and immunohistochemistry for the expression of BMP-2.
Results: BMP-2 mRNA was present in chondrocytes in neonatal growing articular cartilage, but was scarcely present in normal adult articular
cartilage. In OA articular cartilage, BMP-2 mRNA and protein were detected in both clustering and individual chondrocytes in moderately or
severely damaged OA cartilage. In moderately damaged OA cartilage, BMP-2 mRNA was localized in both upper and middle zone
chondrocytes, but was not detected in deep layer chondrocytes. In severely damaged OA cartilage, cellular localization of BMP-2 mRNA was
extended to the deep zone. In the area of osteophyte formation, BMP-2 mRNA was intensely localized in fibroblastic mesenchymal cells,
fibrochondrocytes, chondrocytes and osteoblasts in newly formed osteophytic tissue. The pattern of BMP-2/4 immunolocalization was
associated with that of mRNA localization.
Conclusions: BMP-2 mRNA and BMP-2/4 were detected in cells appearing in OA tissues. BMP-2 was localized in cells of degenerating
cartilage as well as osteophytic tissue. Given the negative localization of BMP-2 in normal adult articular cartilage, BMP-2 might be involved
in the regenerating and anabolic activities of OA cells, which respond to cartilage damage occurring in osteoarthritis.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Science Ltd. All rights reserved.
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Introduction
Osteoarthritic (OA) change in cartilage is characterized by
loss of matrix molecules including proteoglycans and col-
lagen1,2. However, the cells that appear during these
degenerative events are thought to have anabolic actions,
such as proliferation and synthesis of cartilage matrix
components1–3. These cells also reportedly regain the
chondrogenic phenotype and are committed to the regen-
erative pathway, based on the results that Col IIA, a marker
for chondroprogenitor cells, has been reexpressed in OA
cells4.
Various factors may potentiate and regulate this regen-
erating action of OA cells. One of the potent chondrogenic
factors, transforming growth factor-β (TGF-β), was reported
to play a role in the process of osteophyte formation in
animal models5,6 and is expressed in human OA cartilage7.
Bone morphogenetic protein (BMP) is a member of the
TGF-β superfamily, and is a strong bone/cartilage inductive
molecule in vivo and in vitro8,9. Previous immunohistochemi-
cal and in situ hybridization studies clarified that BMP is
induced and localized in cells under various osteochondro-
genic conditions, suggesting the involvement of BMP in
osteo/chondro inductive events in vivo9,10. Furthermore, we
recently reported that several BMP genes are localized at
the site of chondrogenesis in a mice spondylosis model that
histologically resembles the degenerative process of carti-
lage in humans11. To date, almost 30 members of the BMP
family have been identified9, and among its members,
BMP-2 has the capacity to induce osteochondrogenesis3,9,
and reportedly promotes growth and matrix synthesis of
chondrocytes5,12. This chondrogenic action of BMP-2 easily
leads us to question the involvement and role of this mol-
ecule in OA. However, to date, there have been no reports of
the expression and localization of BMP-2 in OA tissue.
The purpose of this study was to elucidate the localiza-
tion of BMP-2 mRNA and protein in surgical OA specimens
and in normal cartilage using immunohistochemistry and
in situ hybridization.
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Fig. 1. Histological sections of moderately damaged OA (a–e; Mankin grade 3), growing (f, g) and normal articular cartilage (h, i).
Safranin-O/fast green staining (a); in situ hybridization (ISH) with antisense (b, c, f, h) and with sense (d) human BMP-2 cRNA probe;
and immunohistochemistry (IH) with anti-BMP-2/4 antibody (e, g, i). (U, upper zone; M, middle zone; D, deep zone; growing, growing
neonatal cartilage; normal, normal adult cartilage) (a) Safranin-O staining was decreased in the upper layer, but preserved in the
middle and deep layers. (b, c) BMP-2 mRNA was detected in individual (arrow) and clustering (arrow head) chondrocytes in the upper
and middle layers (b). In contrast, BMP-2 mRNA was not detected in deep zone cells (c). (d) No signals were detected with sense
probe (continuous section from a). (e) BMP-2/4 was immunolocalized in chondrocytes in the middle zone (M). In contrast,
immunoreactivity was not apparent in deep zone (D) chondrocytes. (f, g) BMP-2 transcripts (f) and positive immunostaining for
BMP-2/4 (g) were observed in articular chondrocytes in human neonatal growing articular cartilage (ankle joint). (h, i) BMP-2
transcripts (h) and positive immunostaining for BMP-2/4 (i) were not detected in cells in normal adult articular cartilage (knee joint).
Original magnification: ×40 (a, d, f, h); ×100 (b, c, e); and ×200 (g, i).
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Materials and methods
TISSUE SAMPLING AND PREPARATION
Cartilage specimens with subchondral bone were ob-
tained from 10 female and four male patients (age range,
65 to 75 years) undergoing endoprosthetic surgery for OA
of the knee joints (medial and lateral femoral condyles
and tibial articular surfaces). All the cases satisfied the
American College of Rheumatology classification criteria
for OA of the knee13. Cases of rheumatoid arthritis were
excluded. Five macroscopically normal cartilage speci-
mens with subchondral bone were obtained from five
patients undergoing amputation (age range, 36 to 66 years;
two medial femoral condyles, two tali of ankle joint and one
metatarsal head of interphalangeal joints). In addition, four
growing articular cartilage samples were obtained from four
patients undergoing amputation (age range, 1 to 4 years;
two tali and two metatarsal heads). Written, informed
Fig. 2. Histological sections of severely damaged OA cartilage (Mankin grade 9). Staining of safranin-O/fast green (a, e); in situ hybridization
(ISH) with antisense human BMP-2 cRNA probe (b, c, f, g); and immunohistochemistry (IH) with anti-BMP-2/4 antibody (d, h). (U, upper zone;
M, middle zone; D, deep zone) (a) Upper zone was essentially lost and staining for safranin-O was lacking in the middle zone. (b) Intense
signals for BMP-2 transcripts were detected in both individual (arrow head) and clustering chondrocytes (arrows) in the middle layer in which
the territorial matrix was less stained by safranin-O. (c) Higher magnification of arrow area in (b) in the middle zone. BMP-2 mRNA was
detected in clustering chondrocytes. (d) Positive immunostaining for BMP-2/4 was detected both in the individual (arrow head) and clustering
(arrow) chondrocytes in the middle layer (nearby section to a). (e) Upper zone was essentially lost and positive staining for safranin-O was
apparent in the territorial matrix of the deep zone chondrocytes. (f) BMP-2 mRNA was localized in middle layer chondrocytes (arrow head).
BMP-2 mRNA was also detected in both individual and clustering chondrocytes in the deep layer (arrow), whose territorial matrix was stained
by safranin-O. (g) Higher magnification of arrow area in (f). BMP-2 mRNA was detected the deep layer chondrocytes. (h) BMP-2/4 was also
immunolocalized in deep layer chondrocytes. Original magnification: ×40 (a, e); ×100 (b, f); ×200 (d, h); and ×400 (c, g).
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consent was obtained from all the patients or legal guard-
ians. Obtained tissues were fixed in 4% paraformaldehyde
(Merck KGaA, Darmstadt, Germany) in PBS (pH, 7.4)
(Sigma Chemical Co., St. Louis, MO) at 37°C for 24 h,
decalcified in 20% EDTA (if needed) and dehydrated in an
ethanol series before being embedded in paraffin as de-
scribed10,14. The size of each section ranged from approxi-
mately 0.8×1 to 1.5×2.8 cm. Each 5-µm section was made
on a microtome, and the sections were stained with
safranin-O/fast green to reveal cartilaginous matrix. Three
sections from each specimen were used for immuno-
histochemistry and in situ hybridization. The histological
samples were graded according to the method of Mankin
et al.15.
PREPARATION OF RNA PROBES
cDNA for human BMP-216 (encoding the propeptide
region relatively specific for BMP-2; with less than 54%
homology with human BMP-4 and less than 33% homology
with human BMP-6 and BMP-7) was subcloned into a
pGEM-T plasmid, and then either linealized by Sac II and
transcribed by SP6 RNA polymerase to generate antisense
probes or linealized by Spe I and transcribed by T3 RNA
polymerase to generate sense probes as described16.
Northern blotting experiments using 32P-labeled antisense
transcripts and the human osteosarcoma cell line showed a
specific band (data not shown). The antisense probe for
18S ribosomal RNA (rRNA) was prepared as described3
and was used to confirm the preservation of RNA in the
tissue specimens.
IN SITU HYBRIDIZATION
In situ hybridization was performed as previously de-
scribed10,16. Briefly, paraffin-embedded sections were de-
waxed, rehydrated, and fixed with 4% paraformaldehyde
for 20 min. The sections were then treated with 0.2 N HCl
for 10 min to inactivate endogenous alkaline phosphatase,
and were acetylated with 0.25% acetic anhydride in 0.1 M
triethanolamine (pH, 8.0) for 10 min. They were then dehy-
drated with an ethanol series and were air-dried. Each
section was covered by 50 µl of hybridization solution (50%
formamide, 10% dextran sulfate, 1×Denhardt’s solution,
600 mM NaCl, 0.25% SDS, 150 µg/ml of Escherichia coli
tRNA, approximately 0.5 µg/ml of RNA probe) and incu-
bated at 50°C for 16 h. After hybridization, the slides were
briefly washed in 5×SSC (1SSC0.15 M NaCl, 0.015 M
sodium citrate) and in 50% formamide, 2×SSC for 30 min at
50°C. RNase A treatment (10 µg/ml) proceeded at 37°C for
30 min. The slides were washed twice with 2×SSC and
0.2×SSC for 20 min at 50°C. Hybridized probes were
detected using a Nucleic Acid Detection Kit (Boehringer
Mannheim GmbH Biochemica, Mannheim, FRG) according
to the manufacturer’s instructions.
Controls included: (i) hybridization with the sense
(mRNA) probe, (ii) RNAse A treatment (20 µg/ml) prior to
hybridization, and (iii) use of neither antisense nor anti-
digoxigenin antibody. The three controls showed no posi-
tive signals. The cell count assessment for positive cells
was done at ×200 magnification using a NIKON ECRIPS
E800M microscope (Nikon, Tokyo, Japan) as described11.
IMMUNOHISTOCHEMISTRY
Immunohistochemistry was performed using the
streptoavidin–peroxidase method with histofine SAB-PO
kits (Nichirei, Tokyo, Japan) as described with minor modi-
fication12. A mouse monoclonal antibody against human
BMP-2/4 (h3b2/17.8.1, kindly donated by Genetics Insti-
tute, Inc., MA)14,15 was used as a primary antibody at a
concentration of 10 µg/ml. Among several BMP members
(BMPs 1 to 7), only BMP-2 and -4 were found to react with
this antibody by immunoblotting with purified recombinant
proteins17. Tissue sections were briefly deparaffinized
and were incubated with 2 mg/ml hyaluronidase in phos-
phate buffered saline (PBS; pH, 7.5) for 20 min. The
sections were digested with 1 mg/ml pronase (Boehringer
Mannheim GmbH Biochemica, Mannheim, FRG) in PBS
(pH, 7.5) and placed in 3% H2O2 in methanol for 30 min to
block endogenous peroxidase. After washing in PBS, the
sections were blocked with 10% normal serum of the same
species as the secondary antibody to minimize background
staining, before being incubated with primary antibody for
2 h at room temperature. Normal serum of the same
species as the primary antibody was used as a control for
the primary antibody. After washing in PBS, the sections
were incubated with secondary antibody at a concentration
of 1:100 (rabbit anti-mouse Ig-G: Nichirei) for 20 min at
room temperature in a humid chamber, and then incubated
with peroxidase-conjugated streptoavidin (Nichirei), again
for 20 min at room temperature in a humid chamber and
washed in PBS. Finally, color reaction was performed using
the substrate reagent 3,3′diaminobenzidine tetrahydro-
chloride (DAB) (Dojindo, Tokyo, Japan). This final solution
contained 120 ml of Tris–HCl (pH, 7.6), 15 mg of DAB and
6.8 µl of 35% H2O2. Sections were counterstained with
hematoxylin and mounted. As a control for immunostaining,
normal serum from the same species as the primary
antibody (mouse-Ig-G) was used.
Results
BMP-2 LOCALIZATION IN OA CARTILAGE
In situ hybridization detected BMP-2 mRNA in cells at
various Mankin grades in OA cartilage (Figs. 1 and 2).
BMP-2 mRNAs were localized in both clustering and indi-
vidual chondrocytes.
In moderately damaged OA cartilage (Mankin grade 3–6;
Fig. 1), staining of safranin-O was still preserved in the
middle and deep layers [Fig. 1(a)]. BMP-2 mRNA was
localized in chondrocytes in both the upper and middle
layers [Fig. 1(b)]. In contrast, BMP-2 transcript was
Table I
Summary of BMP-2 mRNA localization in cells in moderately and
severely damaged OA cartilage
Degree of
damage
Type of
chondrocytes
Zone
Upper Middle Deep
Moderate Individual +∼++ +∼++ −∼±
Clustering +∼+++ ++∼+++ −∼+
Severe Individual * ++∼+++ ++∼+++
Clustering * ++∼+++ +++
Numbers of individual and clustering chondrocytes positive for
BMP-2 mRNA were counted. Ratio indicates positive individual
chondrocytes/total individual chondrocytes, and positive clustering
chondrocytes/total clustering chondrocytes.
−, 0%; ±, ∼10%; +, ∼25%; ++, 25–50%; +++, 50–75%.
*Upper zone was almost lost.
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scarcely detected in deep layer chondrocytes [Fig. 1(c)],
although these cells were positive for 18S rRNA (data not
shown). No signals were detected with BMP-2 sense probe
[Fig. 1(d)]. BMP-2/4 was immunolocalized in the upper
layer (data not shown) and middle layer chondrocytes, but
was scarcely immunolocalized in deep layer chondrocytes
[Fig. 1(e)].
BMP-2 mRNA and BMP-2/4 were localized in neonatal
growing articular chondrocytes [Fig. 1(f,g)]. In contrast,
BMP-2 mRNA was absent and BMP-2/4 was not localized
in normal adult cartilage cells [Fig. 1(h,i)].
In severely damaged OA cartilage (Mankin grade 7–12;
Fig. 2), staining intensity of safranin-O noticeably de-
creased. BMP-2 transcripts were detected not only in
middle zone chondrocytes [Fig. 2(a–c)], but also in deep
zone chondrocytes [Fig. 2(e–g)]. In the middle layer, BMP-2
transcripts were located in clustering chondrocytes whose
territorial matrix lacked safranin-O staining [Fig. 2(a–c)]. In
the deep layer, BMP-2 mRNA was localized in chondro-
cytes whose territorial matrix was stained with safranin-O
[Fig. 2(e–g)]. BMP-2/4 was immunolocalized both in the
middle and deep layer chondrocytes [Fig. 2(d,h)], and
was immunolocalized in both individual and clustering
chondrocytes [Fig. 2(d,h)].
The pattern of BMP-2 mRNA localization in OA cartilage
is summarized in Table I. The pattern of BMP-2/4
immunolocalization was associated with that of mRNA
localization.
BMP-2 LOCALIZATION IN OSTEOPHYTIC TISSUE
BMP-2 mRNA was intensely localized in cells in osteo-
phytic tissue [Fig. 3(a–d)]. BMP-2 transcripts were localized
in fibroblastic cells in the outer fibrous layer [Fig. 3(b,c)], in
fibrochondrocytes in the fibrocartilage layer [Fig. 3(b,d)]
and in osteoblasts in the bone-forming area adjacent to the
chondrogenic layer [Fig. 3(b,d)]. The majority of chondro-
cytes in the deep cartilage layer were positive for BMP-2.
However, chondrocytes in the very deep layer close to the
bone-forming site showed no, or only faint, signals for
BMP-2 transcripts [Fig. 3(b,d)]. BMP-2 transcripts were
absent in osteoblasts located in the relatively mature bone
at the center of the osteophyte [Fig. 3(b)]. No signals were
detected with the BMP-2 sense probe [Fig. 3(e)]. BMP-2/4
immunolocalization was associated with mRNA localization
[Fig. 3(f,g)]. Negative control using normal mouse serum
showed no staining [Fig. 3(h)].
Discussion
To the best of our knowledge, this is the first report to
describe the localization of BMP-2 in human OA tissues.
BMP-2 was scarcely detected in adult normal cartilage, but
was notably present in the OA cells. These findings indicate
the possible synthesis of BMP-2 by OA cells and involve-
ment of BMP-2 in the OA state. BMP-2 was synthesized by
both individual and clustering chondrocytes. Even deep
zone chondrocytes synthesized BMP-2 in severe OA carti-
lage, where cartilage damage was extended to the deeper
area, although these cells did not synthesize BMP-2 when
cartilage damage was less significant. These findings sug-
gest that the zone-specific distribution of BMP-2 may be
dependent on the degree of OA damage.
Our findings of this study, as well as those of previous
reports3,18, indicate that some of the BMP-2 positive cells
are associated with proteoglycan synthesis, as evident by
positive staining for safranin-O in the territorial matrix. This
tendency was particularly marked in the lower middle and
deep layers. OA chondrocytes in the middle and deep
layers reportedly synthesize several cartilaginous colla-
gens3 and aggrecan mRNA18. Another study has reported
that BMP-2 stimulates the synthesis of proteoglycan syn-
thesis in articular cartilage5. Given our results and those of
previous reports, BMP-2 localization in safranin-O positive
areas suggests the possible involvement of BMP-2 in
neo-matrix synthesis occurring in OA tissue. We found
clustering chondrocytes whose territorial matrix lacked
safranin-O staining. These types of cells are thought to be
in a proliferating state2. BMP-2 was localized in these types
of cells and given that BMP-2 reportedly promoted growth
of chondrocytes in in vitro culture experiments12, BMP-2
may be involved in OA cell proliferation as well as matrix
synthesis.
Significant BMP-2 expression was observed in osteo-
phytic tissue. BMP-2 was detected in the early mesenchy-
mal layers as well as in fibrochondrocytes, suggesting the
role of BMP-2 in induction and promotion of osteophyte
formation. Such osteochondro-inductive action of BMP-2
has been proposed by previous in vivo and in vitro stud-
ies8,9. In the present study, the localization of BMP-2 in OA
chondrocytes at various Mankin grades in various zones
and in fibrochondrocytes in the osteophyte is somewhat
similar to that of Col IIA4. As Col IIA is reportedly a marker
for chondroprogenitor cells and binds to BMP-2, BMP-2
may be involved in the early chondrogenic events via the
BMP-2/Col IIA complex, leading to further matrix synthesis
in OA cartilage and osteophyte formation.
As BMP-2/4 could not be detected in the extracellular
matrix (ECM) in OA cartilage during the present experi-
ments, but was localized in OA cells, it is possible that the
amount of BMP-2/4 in ECM is considerably small, or
the lack of BMP-2/4 localization in the ECM might be
due to the technical limitations of the sensitivity of our
Fig. 3. (a) Staining of safranin-O/fast green; in situ hybridization (ISH) (b–d) with antisense and (e) sense human BMP-2 cRNA probes; and
(f, g) immunohistochemistry (IH) with anti-BMP-2/4 antibody and (g) normal mouse serum in histological sections of human osteophytic
tissue. (a, b) BMP-2 mRNA was detected in fibroblastic mesenchymal cells in the outer fibrous layer (F), in fibrochondrocytes in the middle
fibrocartilage layer (FC) and in chondrocytes in the deep chondrocyte layer (DC). In contrast, BMP-2 transcript was absent in cells in the very
deep zone [asterisk in (b)] of the deep cartilage layer close to the bone-forming area. BMP-2 signals were present in osteoblasts in the
bone-forming layer (BF), but absent in cells in mature bone located at the center [double asterisks in (b); (a, b, e, f) are nearby sections]. (c)
Higher magnification of the F and FC layers shown in (b). Intense signals for BMP-2 mRNA were detected in fibroblastic cells (arrow) and
fibrochondrocytes (arrow head). (d) Higher magnification of the DC and the BF layers is presented in (b). BMP-2 transcripts were detected
in chondrocytes (arrow) and osteoblasts (arrow head). In contrast, no, or faint, signals for BMP-2 mRNA were detected in the very deep zone
chondrocytes (asterisk) close to the BF area. (e) No apparent signals were detected in any layer by human BMP-2 sense probe. Positive
BMP-2/4 staining was observed in cells in the outer fibrous (F) layer. (f, g) Positive immunostaining for BMP-2/4 was detected in cells in the
outer fibrous layer (F) (f), the middle fibrocartilage layer (FC) (f and arrow in g), and in chondrocytes in the deep chondrocytes layer (DC)
(g and arrow head in g). (h) Negative control. No immunostaining was observed with mouse normal serum. Original magnification: ×40 (a,
b); ×100 (e, f, h); and ×200 (c, d, g).
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immunohistochemical methods. These possibilities should
be further investigated. In addition, several other growth
factors, such as TGF-β7 insulin-like growth factor19, basic
fibroblast growth factor7, hepatocyte growth factor20, vas-
cular endothelial cell growth factor21 and cartilage-derived
morphogenetic protein-122, are reported to be expressed in
OA cartilage. BMP-2 may act synergistically with these
growth factors or share roles in the metabolism of OA
cartilage. A recent publication, in particular, has proved
the potent role of TGF-β in osteophyte formation in an
experimental animal model6. Future studies should aim to
elucidate the precise roles of BMP-2 in OA change.
In conclusion, this is the first report to demonstrate
BMP-2 localization in OA tissue. The present findings,
together with those of previous reports, suggest the ana-
bolic role of OA chondrocytes via synthesis of BMP-2 and
the potential capacity of articular chondrocytes to synthe-
size BMP-2 in response to the cartilage damage that
occurs in osteoarthritis.
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